Reev Bio Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Seed
- Investors
-
2
Reev Bio General Information
Description
Developer of rapid diagnostic tests intended to make screening for sexually transmitted and blood-borne infections more accessible through home-based testing. The company provides fast and reliable testing kits for various infections, enabling the general public to perform private screenings and receive results quickly without the need for a clinical visit.
Contact Information
Website
www.reevbio.comCorporate Office
- 10 McMahon Street
- Quebec, Quebec G1R 3S4
- Canada
Corporate Office
- 10 McMahon Street
- Quebec, Quebec G1R 3S4
- Canada
Reev Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 12-Aug-2026 | Completed | Startup |
Reev Bio Signals
Reev Bio Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| i4 Capital | Venture Capital | Minority | ||
| Investissement Quebec | PE/Buyout | Minority |
Reev Bio FAQs
-
When was Reev Bio founded?
Reev Bio was founded in 2023.
-
Where is Reev Bio headquartered?
Reev Bio is headquartered in Quebec, Canada.
-
What is the size of Reev Bio?
Reev Bio has 3 total employees.
-
What industry is Reev Bio in?
Reev Bio’s primary industry is Clinics/Outpatient Services.
-
Is Reev Bio a private or public company?
Reev Bio is a Private company.
-
What is Reev Bio’s current revenue?
The current revenue for Reev Bio is .
-
Who are Reev Bio’s investors?
i4 Capital and Investissement Quebec have invested in Reev Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process